文献速递关节外科

interim占位器更换治疗假体周围感染:近半数患者最终失败

Interim Spacer Exchange for Treatment of Periprosthetic Joint Infection: Almost Half the Patients Subsequently Fail.
PubMed 文献 · J Arthroplasty · 2021-08-30

研究纳入2000至2017年两机构182例因假体周围感染行占位器更换的患者,评估其生存率与失败危险因素。总体失败率为49%,多数失败发生在2年内;晚期宿主分级C是唯一与治疗失败独立相关的因素。

要点

  • 占位器更换后总体失败率49%,60%的失败发生在2年内。
  • 晚期宿主分级C是唯一与治疗失败独立相关的因素。
  • 免疫抑制状态及更换前曾行翻修者失败率更高。

核心结论

  • 近半数接受占位器更换的患者未能完成预期的二期翻修关节成形术。

研究设计与样本

  • 回顾性队列研究,利用两个机构数据库纳入2000至2017年行占位器更换的182例患者。

主要发现

  • 总体失败率为49%,多数患者(60%)在2年内失败。
  • 失败患者中更高合并症评分、红细胞沉降率升高及非白人种族更常见。
  • 未失败患者中更换时培养阴性更常见。
  • 免疫抑制状态及更换前曾行翻修者失败率更高。
  • 校正临床相关变量后,晚期宿主分级C是唯一与治疗失败相关的因素。

关键数值与推荐

  • 总体失败率49%,其中60%的失败发生在2年内。
  • 晚期宿主分级C是唯一与治疗失败独立相关的因素。

临床怎么用

  • 对具有高合并症评分、红细胞沉降率升高、非白人种族、免疫抑制或更换前曾翻修等危险因素的患者,应权衡更换占位器增加抗生素负荷的获益与不良结局风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Interim spacer exchange may be performed in patients undergoing 2-stage exchange for periprosthetic joint infection. Several studies have demonstrated that interim spacer exchange is associated with poor outcomes. This study investigated the survivorship and risk factors for failure in patients with an interim spacer exchange. METHODS: Two institutional databases identified 182 patients who underwent spacer exchange from 2000 to 2017. Primary outcomes included progression to reimplantation, treatment success, and mortality. Bivariate analysis was performed to evaluate risk factors associated with failure. Kaplan-Meier curves using host and local grades were generated to evaluate for primary outcomes and differences in survivorship. RESULTS: The overall failure rate was 49% in patients with a spacer exchange. Most patients (60%) failed before 2 years. Higher comorbidity scores, elevated erythrocyte sedimentation rate, and non-White race were more prevalent in patients who failed. Negative cultures at the time of exchange were more prevalent in patients who did not fail. Failure rate was higher in immunocompromised conditions, and those who had revision prior to exchange. After considering clinically relevant variables, advanced host grade C was the single factor associated with treatment failure. Although survivorship curves were not significantly different between extremity local grades, higher host grades were associated with treatment failure. CONCLUSION: Almost 1 out of 2 patients with spacer exchange were found to fail the intended 2-stage revision arthroplasty. Benefits of delivering additional antibiotic load with a new spacer should be balanced against poor outcomes in patients with the aforementioned risk factors.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Kozaily E, Tan TL, Yacovelli S, et al. Interim Spacer Exchange for Treatment of Periprosthetic Joint Infection: Almost Half the Patients Subsequently Fail. J Arthroplasty. 2021. PMID: 34563436. doi:10.1016/j.arth.2021.08.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。